Portrait of Maanasa Indaram
ucsf logobch logo

Maanasa Indaram, MD

Pediatric Ophthalmology • StrabismusMedical Director, Adult Strabismus, San Francisco
Strabismus & Eye Motility Disorders Mission Bay
415-353-2020
Portrait of Maanasa Indaram
Portrait of Maanasa Indaram
ucsf logobch logo

Maanasa Indaram, MD

Pediatric Ophthalmology • StrabismusMedical Director, Adult Strabismus, San Francisco
Strabismus & Eye Motility Disorders Mission Bay
415-353-2020

On this page

About me

Dr. Maanasa Indaram is an ophthalmologist who cares for children with all types of eye conditions, as well as adults with strabismus (abnormal eye alignment), eye movement disorders and keratoconus (a vision-affecting disorder of the cornea). She specializes in treating strabismus with glasses, botulinum toxin (Botox) injections or eye muscle surgery, and has expertise in a minimally invasive procedure called corneal cross-linking to treat keratoconus in both adults and children, including those with neurodevelopmental disorders. In addition, she has expertise in managing pediatric cataracts, anterior segment diseases (disorders of the front of the eye), amblyopia (lazy eye), ptosis (drooping upper eyelid) and orbital dermoid cysts.

Indaram serves as medical director of UCSF's pediatric ophthalmology division and adult strabismus clinic, and she co-directs pediatric ophthalmology and adult strabismus at Zuckerberg San Francisco General Hospital and Trauma Center. Her research interests include treatments for strabismus and keratoconus.

Indaram earned her medical degree at Duke University School of Medicine. She completed a residency in ophthalmology at UCSF, followed by a fellowship in pediatric ophthalmology and adult strabismus at Boston Children's Hospital and Massachusetts Eye and Ear, both affiliates of Harvard Medical School's ophthalmology department.

Indaram is a member of the American Association for Pediatric Ophthalmology and Strabismus, American Academy of Ophthalmology, Pediatric Eye Disease Investigator Group, Association for Research in Vision and Ophthalmology, Frederick C. Cordes Eye Society and Alpha Omega Alpha Honor Medical Society.

Education & training

Board certification

  • Ophthalmology, American Board of Ophthalmology

Fellowship

  • Ophthalmology, Childrens Hospital of Boston - GME

Residency

  • Ophthalmology, UCSF Graduate Medical Education

Internship

  • Transitional, Memorial Sloan-Kettering Cancer Center (GME)

Degree

  • MD, Duke University School of Medicine

My expertise

  • Specialties
  • Conditions
    • Ocular Motility Disorders
    • Blocked Tear Duct
    • Strabismus
    • Nystagmus
    • Lazy Eye
    • Cataract

Locations

    Reviews

    Average rating

    5
    5 out of 5 Stars
    89 ratings
    About provider reviews

    Showing 1-6 of 19 reviews

    Sort by
    • 5 out of 5 Stars
      January 29, 2026

      The treatment as well as my interaction with all of the providers was beyond expectation. The surgery and its results has been life changing for me. As a result, I feel like I can look forward to things again and can get on the path of a more healthy lifestyle. I am so thankful!

    • 5 out of 5 Stars
      December 28, 2025

      Such a pleasure to have such a great expert in rare eye condition and knowledge of seeing patients with Down Syndome

    • 5 out of 5 Stars
      December 14, 2025

      Excellent orthoptist

    • 5 out of 5 Stars
      November 22, 2025

      I have received excellent care from all the staff I have seen

    • 5 out of 5 Stars
      November 13, 2025

      Really great staff and clean offices

    • 5 out of 5 Stars
      October 2, 2025

      The Dr. is very friendly

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.